US 11,447,742 B2 · Compositions and methods for activation and overexpression of secondary metabolites in microorganisms

Abstract

Methods and compositions herein provide non-naturally occurring γ-butyrolactones (GBLs) in racemic mixtures that increase efficiency and effectiveness of screening for production of antibiotics, and enhance yields and express silent pathways. Non-naturally occurring GBLs were synthesized and found to stimulate antibiotic production in several different streptomycete strains. Antibiotic production by Streptomyces coelicolor was induced by a racemic mixture of non-cognate stereoisomers of VB-D, seven of which are non-naturally occurring. Further, novel A-factor-type GBL analogs stimulated antibiotic production in S. coelicolor. Synthesis in response to the treatment with the non-cognates GBL was observed for known compounds including undecylprodigiosin, desferrioxamine and streptorubin B, as was synthesis of a compound of unknown structure. A group of 37 additional microbial strains was screened by principal component analysis to determine optimal concentrations of each of a panel of four non-cognate synthetic GBLs for addition to cultures with optimal stimulation of secondary metabolites, and large scale fermentations were analyzed and product enhancement by the GBLs was observed.

Claims7

Dependent claims

A method of improving a yield of a microbially-produced bioactive secondary metabolite product, the method comprising

contacting cells of at least one strain of microorganism with a suitable amount of γ-butyrolactone (GBL) racemic mixture wherein the GBL is non-cognate to the strain, is synthetic, and is non-naturally occurring, and comprises two or more of the compositions selected from formulas I-VII
and culturing the cells of the strain with the GBL for production of the bioactive product;
and,
obtaining the product from the cells by separation of cells and medium or purification of the product from the cells and analyzing the amount of the product, wherein the yield of the product per unit of volume of culture or weight of cells is at least two-fold greater than that from control cells of the strain not contacted with the GBL compositions and otherwise identically cultured and analyzed, wherein the yield of the product from the cells cultured with the GBL is improved by at least two-fold compared to that from the control cells.

1 more element

Dependencies are inferred from the claim text.

Compositions and methods for activation and overexpression of secondary metabolites in microorganisms

Life of this patent

Compositions and methods for activation and overexpression of secondary metabolites in microorganisms

Life of this patent

Abstract

Claims7